Integra Lifesciences Holdings Corp (IART)
23.56
+0.56
(+2.43%)
USD |
NASDAQ |
Nov 22, 10:40
Integra Lifesciences Holdings Shareholders Equity (Quarterly): 1.522B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.522B |
June 30, 2024 | 1.534B |
March 31, 2024 | 1.598B |
December 31, 2023 | 1.588B |
September 30, 2023 | 1.579B |
June 30, 2023 | 1.683B |
March 31, 2023 | 1.675B |
December 31, 2022 | 1.804B |
September 30, 2022 | 1.724B |
June 30, 2022 | 1.661B |
March 31, 2022 | 1.615B |
December 31, 2021 | 1.685B |
September 30, 2021 | 1.632B |
June 30, 2021 | 1.575B |
March 31, 2021 | 1.529B |
December 31, 2020 | 1.515B |
September 30, 2020 | 1.398B |
June 30, 2020 | 1.349B |
March 31, 2020 | 1.342B |
December 31, 2019 | 1.417B |
September 30, 2019 | 1.385B |
June 30, 2019 | 1.421B |
March 31, 2019 | 1.397B |
December 31, 2018 | 1.376B |
September 30, 2018 | 1.365B |
Date | Value |
---|---|
June 30, 2018 | 1.342B |
March 31, 2018 | 998.44M |
December 31, 2017 | 962.31M |
September 30, 2017 | 913.12M |
June 30, 2017 | 894.56M |
March 31, 2017 | 852.49M |
December 31, 2016 | 839.67M |
September 30, 2016 | 823.43M |
June 30, 2016 | 794.79M |
March 31, 2016 | 776.39M |
December 31, 2015 | 751.44M |
September 30, 2015 | 730.10M |
June 30, 2015 | 711.72M |
March 31, 2015 | 688.10M |
December 31, 2014 | 704.32M |
September 30, 2014 | 685.98M |
June 30, 2014 | 689.23M |
March 31, 2014 | 679.20M |
December 31, 2013 | 666.09M |
September 30, 2013 | 499.48M |
June 30, 2013 | 516.59M |
March 31, 2013 | 509.89M |
December 31, 2012 | 517.78M |
September 30, 2012 | 526.70M |
June 30, 2012 | 507.21M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.342B
Minimum
Mar 2020
1.804B
Maximum
Dec 2022
1.571B
Average
1.584B
Median
Shareholders Equity (Quarterly) Benchmarks
Boston Scientific Corp | 20.71B |
Haemonetics Corp | 878.85M |
ResMed Inc | 5.195B |
Globus Medical Inc | 4.069B |
Perspective Therapeutics Inc | 328.47M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 4.066B |
Total Liabilities (Quarterly) | 2.544B |
Debt to Equity Ratio | 1.187 |
Current Ratio | 1.205 |
Net Debt Paydown Yield | -5.39% |